Inovio Pharmaceuticals, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Peter Kies. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Peter Kies has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:INO / Inovio Pharmaceuticals, Inc. CFO 30,257
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Peter Kies. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases INO / Inovio Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in INO / Inovio Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-10-09 INO KIES PETER 3,960 10.1000 330 121.2000 39,996 8 147.72 8,752 21.88
2012-06-05 INO KIES PETER 25,000 0.4100 2,083 4.9200 10,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Sales INO / Inovio Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in INO / Inovio Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2018-11-29 INO KIES PETER 10,001 5.2800 833 63.3600 52,805 306 23.64 -33,113 -62.71
2018-07-10 INO KIES PETER 10,000 4.4500 833 53.4000 44,500
2018-07-09 INO KIES PETER 25,000 4.4300 2,083 53.1600 110,750

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Peter Kies as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-16 2025-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,566 30,257 -7.82 1.95 -5,004 59,001
2025-05-16 2025-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,771 32,823 17.01
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,960 28,052 -9.54 1.98 -5,861 55,543
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,010 31,012 19.27
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,362 26,002 -8.33 1.98 -4,677 51,484
2025-02-28 2025-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,997 28,364 16.40
2024-05-16 2024-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,562 24,367 -9.51 13.07 -33,485 318,477
2024-05-16 2024-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,771 26,929 21.53
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,358 22,158 -9.62 8.16 -19,241 180,809
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,997 24,516 19.48
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,108 20,519 -5.12 8.16 -9,041 167,435
2024-02-28 2024-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,878 21,627 9.51
2023-03-13 2023-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -31,410 236,999 -11.70 1.13 -35,493 267,809
2023-03-13 2023-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 59,737 268,409 28.63
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -28,195 208,672 -11.90 1.28 -36,090 267,100
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 47,967 236,867 25.39
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -12,928 188,900 -6.41 1.28 -16,548 241,792
2023-02-28 2023-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22,544 201,828 12.57
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -59,737 59,737 -50.00
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -31,410 179,284 -14.91 3.22 -101,140 577,294
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 59,737 210,694 39.57
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -21,466 0 -100.00
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -11,287 150,957 -6.96 3.26 -36,796 492,120
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 21,466 162,244 15.25
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 143,900 143,900
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 192,800 192,800
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -22,545 45,088 -33.33
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -12,555 140,778 -8.19 3.22 -40,427 453,305
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 22,545 153,333 17.24
2021-06-11 2021-06-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -13,750 20,000 -40.74
2021-06-11 2021-06-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -33,750 130,788 -20.51 10.01 -337,838 1,309,188
2021-06-11 2021-06-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13,750 164,538 9.12 2.16 29,700 355,402
2021-06-04 2021-06-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,000 150,788 -6.22 8.03 -80,300 1,210,828
2021-04-21 2021-04-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,000 160,788 -5.86 8.52 -85,200 1,369,914
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -59,737 119,474 -33.33
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -31,410 170,788 -15.53 10.57 -332,004 1,805,229
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 59,737 202,198 41.93
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -21,467 21,466 -50.00
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -11,288 142,461 -7.34 8.91 -100,576 1,269,328
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 21,467 153,749 16.23
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -27,566 0 -100.00
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -14,574 132,282 -9.92 9.19 -133,935 1,215,672
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 27,566 146,856 23.11
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 67,633 67,633
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 104,833 104,833
2021-01-15 2021-01-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -30,000 0 -100.00
2021-01-15 2021-01-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -30,000 119,290 -20.10 10.02 -300,558 1,195,119
2021-01-15 2021-01-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30,000 149,290 25.15 4.56 136,800 680,762
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -11,250 33,750 -25.00
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -8,750 0 -100.00
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20,000 119,290 -14.36 10.69 -213,706 1,274,649
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,250 139,290 8.79 2.16 24,300 300,866
2020-12-17 2020-12-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,750 128,040 7.34 2.40 21,000 307,296
2020-07-17 2020-07-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -35,000 0 -100.00
2020-07-17 2020-07-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -35,000 119,290 -22.68 24.95 -873,208 2,976,142
2020-07-17 2020-07-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 35,000 154,290 29.34 2.40 84,000 370,296
2020-07-02 2020-06-30 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -35,000 119,290 -22.68 26.50 -927,500 3,161,185
2020-03-12 2020-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 179,211 179,211
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -20,433 0 -100.00
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -7,066 154,290 -4.38 5.70 -40,276 879,453
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20,433 161,356 14.50
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -21,467 42,933 -33.33
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -7,424 140,923 -5.00 14.09 -104,604 1,985,605
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 21,467 148,347 16.92
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -27,567 27,566 -50.00
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -9,817 126,880 -7.18 9.80 -96,207 1,243,424
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 27,567 136,697 25.26
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -20,433 20,433 -50.00
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -7,066 109,130 -6.08 3.34 -23,600 364,494
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20,433 116,196 21.34
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -25,000 0 -100.00
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -8,591 95,763 -8.23 3.34 -28,694 319,848
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25,000 104,354 31.50
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 64,400 64,400
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 100,500 100,500
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -27,567 55,133 -33.33
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -10,301 79,354 -11.49 3.61 -37,187 286,468
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 27,567 89,655 44.40
2018-11-30 2018-11-29 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -10,001 0 -100.00
2018-11-30 2018-11-29 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,001 62,088 -13.87 5.28 -52,805 327,825
2018-11-30 2018-11-29 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,001 72,089 16.11 2.00 20,002 144,178
2018-07-11 2018-07-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,000 62,088 -13.87 4.45 -44,500 276,292
2018-07-11 2018-07-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -15,000 0 -100.00
2018-07-11 2018-07-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -25,000 72,088 -25.75 4.43 -110,750 319,350
2018-07-11 2018-07-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15,000 97,088 18.27 4.24 63,600 411,653
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -20,434 40,866 -33.33
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6,899 82,088 -7.75 4.51 -31,114 370,217
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 20,434 88,987 29.81
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -25,000 25,000 -50.00
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -8,421 68,553 -10.94 4.51 -37,979 309,174
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25,000 76,974 48.10
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 82,700 82,700
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 126,500 126,500
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,333 0 -100.00
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,407 51,974 -6.15 4.29 -14,616 222,968
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,333 55,381 17.71
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 61,300 61,300
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 100,000 100,000 6.68 668,000 668,000
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -25,000 50,000 -33.33
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -9,171 47,048 -16.31 6.61 -60,620 310,987
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 25,000 56,219 80.08
2017-03-07 2017-03-06 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,640 31,219 -10.44 6.95 -25,298 216,972
2017-03-07 2017-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,333 8,333 -50.00
2017-03-07 2017-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,333 34,859 31.41
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 75,000 75,000
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 67,500 67,500 7.02 473,850 473,850
2016-03-08 2016-03-07 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,196 26,526 -10.75 7.48 -23,906 198,414
2016-03-08 2016-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,334 16,666 -33.34
2016-03-08 2016-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,334 29,722 38.97
2015-03-09 2015-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 60,000 60,000 7.56 453,600 453,600
2015-03-09 2015-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 25,000 25,000
2014-10-09 2014-10-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 3,960 21,388 22.72 10.10 39,996 216,019
2014-05-23 2014-05-22 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 155,000 155,000 2.20 341,000 341,000
2014-03-27 2014-03-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 150,000 150,000 3.23 484,500 484,500
2013-03-18 2013-03-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 180,000 180,000 0.54 97,200 97,200
2012-06-05 2012-06-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 25,000 69,712 55.91 0.41 10,250 28,582
2012-02-27 2012-02-23 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 175,000 175,000 0.60 105,000 105,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)